Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Predictive Power of Serum Vitamin D for Poor Outcomes in Covid-19 Patients Publisher



Derakhshanian H1, 2 ; Rastad H3 ; Ghosh S4 ; Zeinali M5 ; Ziaee M5 ; Khoeini T5 ; Farrokhpour M6 ; Qorbani M3 ; Ramezani Ghamsari M7 ; Hasani H8 ; Mirzaasgari Z5, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biochemistry Genetics and Nutrition, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
  2. 2. Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran
  3. 3. Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  4. 4. Department of Biology Okanagan Campus, University of British Columbia, Kelowna, BC, Canada
  5. 5. Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Internal Medicine, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
  7. 7. Clinical Research Development Unit, Shahid Rajaei Educational and Medical Center, Alborz University of Medical Sciences, Karaj, Iran
  8. 8. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Shefa Neuroscience Research Center, Tehran, Iran

Source: Food Science and Nutrition Published:2021


Abstract

Considering the high prevalence of vitamin D deficiency worldwide and its relationship with immune response to viral infections, this study attempted to identify the predictive power of serum vitamin D for poor outcomes among the COVID-19 patients. This retrospective cohort study included all patients with confirmed COVID-19 hospitalized between February 20, 2020, and April 20, 2020, at a designated COVID-19 hospital, located in Tehran province, Iran. General characteristics, medical history and clinical symptoms were recorded by trained physicians. Blood parameters including complete blood count, creatinine, lactate dehydrogenase, creatine phosphokinase, erythrocyte sedimentation rate, C-reactive protein and vitamin D were tested. This study included 290 hospitalized patients with COVID-19 (the mean age [SD]: 61.6 [16.9], 56.6% males), of whom 142 had vitamin D concentrations less than 20 ng/ml, defined as vitamin D deficiency. COVID-19 patients with vitamin D deficiency were more likely to die (Crude OR [95% CI]: 2.30 [1.25–4.26]), require ICU (2.06 [1.22–3.46]) and invasive mechanical ventilation (2.03 [1.04–3.93]) based on univariate logistic regression results. Although, after adjusting for potentials confounders such as gender and age, the association between vitamin D and need to invasive mechanical ventilation lost its significance, adjusted values for the risk of death and ICU requirement were still statistically significant. Vitamin D deficiency can be considered as a predictor of poor outcomes and mortality in COVID-19 patients. Therefore, checking serum 25 (OH) D on admission and taking vitamin D supplements according to the prophylactic or treatment protocols is recommended for all COVID-19 patients. © 2021 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC
Other Related Docs
15. Covid-19 Infection and Vitamin D: Current Scenario and Future Prospects, Current Drug Discovery Technologies (2021)
16. The Role of Emergency Radiology in Covid-19: From Preparedness to Diagnosis, Canadian Association of Radiologists Journal (2020)
33. The Prophylaxis and Treatment Potential of Supplements for Covid-19, European Journal of Pharmacology (2020)
37. Covid-19 and Cancer: A Comparative Case Series, Cancer Treatment and Research Communications (2021)
42. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)